A Registry of COPD Patients to be Used for Future Studies
The Ohio State University COPD Registry
1 other identifier
observational
9
1 country
1
Brief Summary
To develop a cohort of COPD participants to assist study staff in determining the most likely candidates for future studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 23, 2008
CompletedFirst Posted
Study publicly available on registry
December 24, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedOctober 29, 2021
October 1, 2021
2 years
December 23, 2008
October 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
This is a registry protocol to determine factors contributing to the development of chronic obstructive lung disease.
Secondary Outcomes (1)
To develop a repository of blood from subjects with COPD for future studies. These studies may include evaluation of biologic markers of disease severity and progression.
Study Arms (1)
Chronic obstructive lung disease
those with a condition
Eligibility Criteria
primary care clinic
You may qualify if:
- Patients who are 18 years of age and older who have been diagnosed with COPD by at least one of the following:
- clinical history-a documented history of COPD, emphysema, or chronic bronchitis;
- pulmonary function results (defined as an FEV1/FVC less than 0.7;
- radiographic results (high-resolution CT findings of emphysema
You may not qualify if:
- in ability to give informed consent
- prisoners
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Philip Diazlead
Study Sites (1)
The Ohio State University
Columbus, Ohio, 43210, United States
Biospecimen
whole blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philip Diaz, MD
Ohio State University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Philip Diaz M.D.
Study Record Dates
First Submitted
December 23, 2008
First Posted
December 24, 2008
Study Start
December 1, 2008
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
October 29, 2021
Record last verified: 2021-10